Keyword Search Subscribe to receive breaking news alerts about uniQure. Subscribe Year None20262025202420232022202120202019201820172016 Date Title Jun 25, 2026 uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares Jun 23, 2026 uniQure Announces Pricing of Upsized $225 Million Public Offering Jun 22, 2026 uniQure Announces $150 Million Proposed Public Offering Jun 19, 2026 uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy Jun 17, 2026 uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease May 05, 2026 uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »